Ginger extract adjuvant to doxorubicin in mammary carcinoma: study of some molecular mechanisms
- 335 Downloads
The present study aimed to investigate the molecular mechanisms underlying the anticancer properties of ginger extract (GE) in mice bearing solid Ehrlich carcinoma (SEC) and to evaluate the use of GE in combination with doxorubicin (DOX) as a complementary therapy against SEC.
SEC was induced in 60 female mice. Mice were divided into four equal groups: SEC, GE, DOX and GE + DOX. GE (100 mg/kg orally day after day) and DOX (4 mg/kg i.p. for 4 cycles every 5 days) were given to mice starting on day 12 of inoculation. On the 28th day, blood samples were collected, mice were scarified, tumor volume was measured, and tumor tissues were excised.
The anti-cancer effect of GE was mediated by activation of adenosine monophosphate protein kinase (AMPK) and down-regulation of cyclin D1 gene expression. GE also showed pro-apoptotic properties as evidenced by elevation of the P53 and suppression of nuclear factor-kappa B (NF-κB) content in tumor tissue. Co-administration of GE alongside DOX markedly increased survival rate, decreased tumor volume, and increased the level of phosphorylated AMPK (PAMPK) and improved related pathways compared to DOX group. In addition, the histopathological results demonstrated enhanced apoptosis and absence of multinucleated cells in tumor tissue of GE + DOX group.
AMPK pathway and cyclin D1 gene expression could be a molecular therapeutic target for the anticancer effect of GE in mice bearing SEC. Combining GE and DOX revealed a greater efficacy as anticancer therapeutic regimen.
KeywordsAMPK Cyclin D1 Doxorubicin Ginger Mammary carcinoma Solid Ehrlich carcinoma
Authors gratefully acknowledge Dr. Mona A. Yehia, Professor of Histochemistry and Cell Biology, Medical Research Institute, Alexandria, for conducting and interpreting the histopathological examination.
- 5.Xie Y, Wan W, Zhao Y, Xie J, Wu Q (2016) Impacts on asthma at persistent stage and immune function in the patients treated with acupuncture for warming yang and benefiting qi. Zhongguo Zhen Jiu 35(11):1089–1093Google Scholar
- 9.Höferl M, Stoilova I, Wanner J, Schmidt E, Jirovetz L, Trifonova D et al (2015) Composition and comprehensive antioxidant activity of ginger (Zingiber officinale) essential oil from Ecuador. Nat Prod Commun 10(6):1085–1090Google Scholar
- 11.Anfenan ML (2014) Evaluation of nutritional and anti-diabetic activity of different forms of ginger in rats. Middle East J Sci Res 21(1):56–62.Google Scholar
- 15.Plengsuriyakarn T, Viyanant V, Eursitthichai V, Tesana S, Chaijaroenkul W, Itharat A et al (2012) Cytotoxicity, toxicity, and anticancer activity of Zingiber officinale Roscoe against cholangiocarcinoma. Asia Pac J Cancer Prev 9:4597–4606Google Scholar
- 16.Jeena K, Liju VB, Kuttan R (2013) Antioxidant, anti-inflammatory and anti-nociceptive activities of essential oil from ginger. Indian J Physiol Pharmacol 57(1):51–62Google Scholar
- 24.Osman Ael-M, Ahmed MM, Khayyal MT, el-Merzabani MM (1993) Hyperthermic potentiation of ciplatin cytotoxicity on solid Ehrlich carcinoma. Tumori 79(4):268–272Google Scholar
- 26.Glasel J (1995) Validity of nucleic acid purities monitored by 260 nm/280 nm absorbance ratios. Biotechniques 18(1):62–63Google Scholar
- 28.Field A (2009) Discovering statistics using SPSS. Sage, LondonGoogle Scholar
- 42.Abdullah S, Zainal Abidin SA, Murad NA, Makpol S, Wan Ngah WZ, Yusof YA (2010) Ginger extract (Zingiber officinale) triggers apoptosis and G0/G1 cells arrest in HCT 116 and HT 29 colon cancer cell lines. Afr J Biochem Res 4(4):134–42Google Scholar
- 46.Huang KZ, Nie DN, Yin SM, Li YQ, Xie SF, Ma LP et al (2011) Cyclin D1, hTERT expression and telomerase activity in HL-60 and HL-60A cell lines and their significance. J Exp Hematol 19(4):911–915Google Scholar
- 48.Ruderman NB, Xu XJ, Nelson L, Cacicedo JM, Saha AK, Lan F, Ido Y (2010) AMPK and SIRT1: a long-standing partnership? Am J Physiol Endoc M 298(4):E751–E760Google Scholar
- 50.Mohanty S, Mohanty A, Sandoval N, Tran T, Bedell V, Wu J et al (2016) Cyclin D1 depletion induces DNA damage in mantle cell lymphoma lines. Leukemia Lymphoma 23:1–3Google Scholar